Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Clinical trial NCT05680818 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05680818
- Sponsor
- Calcilytix Therapeutics, Inc., a BridgeBio company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-06
- Primary completion
- 2025-08-22
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.